Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Three Arm, Randomized, Open Label Clinical Study to Compare Renal Function in Liver Transplant Recipients Receiving an Immunosuppressive Regimen of Advagraf (Immediately or Delayed Post-transplant) and MMF With or Without a Monoclonal Anti-IL2R Antibody (Basiliximab)

NCT01011205 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT01011205
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01011205 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Three Arm, Randomized, Open Label Clinical Study to Compare Renal Function in Liver Transplant Recipients Receiving an Immunosuppressive Regimen of Advagraf (Immediately or Delayed Post-transplant) and MMF With or Without a Monoclonal Anti-IL2R Antibody (Basiliximab)
Lead sponsor
Astellas Pharma Inc
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2009
Completion date
January 4, 2013
Enrollment
893 (actual)
Sites
72

Conditions

As the registry lists them; a condition with its own page is linked.

liver transplantation